
Atropine therapy slows the progression of myopia via medicative means. It’s an ideal myopia treatment for younger patients who are not yet candidates for our other treatments. Atropine is dosed once daily, but the strength of the eye drop is chosen depending on the severity of your child’s myopic progression.

Novel myopia spectacles are the latest myopia treatment to be FDA-approved! They differ from normal spectacles in that they slow the progression of myopia instead of contributing to it. This is a great treatment option that bridges the gap between Atropine and our contact lens-based options.

Multifocal contact lenses are a very specific type of soft contact lens that has been demonstrated to slow progression as a myopia treatment. For myopic children or teens whose eyes are still worsening with traditional soft contacts, multifocal contact lenses represent a logical transition.

Your child wears these custom-designed lenses to sleep and wakes up seeing clearly without needing glasses or contacts! Our specialized design software allows us to design a lens from a 3D scan of your child’s eyes, thereby creating the most protective, accurate, and healthiest lens for your child.
*First note. As more efficacious myopia treatments are available, they will be added to the list above. Lumen Optometric relies heavily on treatments that have been thoroughly researched and vigorously tested in order to make sure they work well and are safe for your children.
**Note, the reduction of myopic progression has been demonstrated in numerous studies for the treatments above, but the FDA has yet to make an official myopia treatment statement for atropine.
